Bilimsel Makale Arama | NeuralCipher AI

Kaynak kaydı

Loss of phosphodiesterase 10A expression is associated with progression and severity in Parkinson's disease.

Niccolini F, Foltynie T, Reis Marques T, Muhlert N, Tziortzi AC, Searle GE, Natesan S, Kapur S, Rabiner EA, Gunn RN, Piccini P, Politis M.

Brain · 2015-07-25

DOI: 10.1093/brain/awv219PMID: 26210536

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Impact of Depression on Progression of Impairment and Disability in Early Parkinson's Disease.

Bega D, Luo S, Fernandez H, Chou K, Aminoff M, Parashos S, Walker H, Russell DS, Christine CW, Dhall R, Singer C, Bodis-Wollner I, Hamill R, Truong D, Mari Z, Glazmann S, Huang M, Houston E, Simuni T.

Mov Disord Clin Pract · 2015-07-14

DOI: 10.1002/mdc3.12205PMID: 28393083

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

The Natural Progression of Parkinson's Disease in a Small Cohort with 15 Drug-naïve Patients.

Liu Y, Fan JH, Gao X, Ma L, Qiao YL, Zhang L.

Chin Med J (Engl) · 2015-07-01

DOI: 10.4103/0366-6999.159350PMID: 26112717

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Vascular risk factors aggravate the progression of Parkinson's disease: a five-year follow-up study in Chinese patients.

Li HJ, Yu Y, Chen Y, Liang HY.

Int J Clin Exp Med · 2015-06-15

PMID: 26309021

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Syntax, action verbs, action semantics, and object semantics in Parkinson's disease: Dissociability, progression, and executive influences.

Bocanegra Y, García AM, Pineda D, Buriticá O, Villegas A, Lopera F, Gómez D, Gómez-Arias C, Cardona JF, Trujillo N, Ibáñez A.

Cortex · 2015-06-03

DOI: 10.1016/j.cortex.2015.05.022PMID: 26103601

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Abnormal Olfaction in Parkinson's Disease Is Related to Faster Disease Progression.

Cavaco S, Gonçalves A, Mendes A, Vila-Chã N, Moreira I, Fernandes J, Damásio J, Teixeira-Pinto A, Bastos Lima A.

Behav Neurol · 2015-06-02

DOI: 10.1155/2015/976589PMID: 26136625

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Novel recruitment strategy to enrich for LRRK2 mutation carriers.

Foroud T, Smith D, Jackson J, Verbrugge J, Halter C, Wetherill L, Sims K, Xin W, Arnedo V, Lasch S, Marek K, Parkinson's Progression Markers Initiativea.

Mol Genet Genomic Med · 2015-05-06

DOI: 10.1002/mgg3.151PMID: 26436106

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Clinically meaningful parameters of progression and long-term outcome of Parkinson disease: An international consensus statement.

Puschmann A, Brighina L, Markopoulou K, Aasly J, Chung SJ, Frigerio R, Hadjigeorgiou G, Kõks S, Krüger R, Siuda J, Wider C, Zesiewicz TA, Maraganore DM.

Parkinsonism Relat Disord · 2015-05-01

DOI: 10.1016/j.parkreldis.2015.04.029PMID: 25952959

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Features of alpha-synuclein that could explain the progression and irreversibility of Parkinson's disease.

Gallegos S, Pacheco C, Peters C, Opazo CM, Aguayo LG.

Front Neurosci · 2015-03-09

DOI: 10.3389/fnins.2015.00059PMID: 25805964

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Transcranial magnetic stimulation follow-up study in early Parkinson's disease: A decline in compensation with disease progression?

Kojovic M, Kassavetis P, Bologna M, Pareés I, Rubio-Agusti I, Berardelli A, Edwards MJ, Edwards MJ, Rothwell JC, Bhatia KP.

Mov Disord · 2015-03-05

DOI: 10.1002/mds.26167PMID: 25753906

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease.

Weintraub D, Simuni T, Caspell-Garcia C, Coffey C, Lasch S, Siderowf A, Aarsland D, Barone P, Burn D, Chahine LM, Eberling J, Espay AJ, Foster ED, Leverenz JB, Litvan I, Richard I, Troyer MD, Hawkins KA, Parkinson's Progression Markers Initiative.

Mov Disord · 2015-03-04

DOI: 10.1002/mds.26170PMID: 25737166

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Non-motor symptoms in an Indian cohort of Parkinson's disease patients and correlation of progression of non-motor symptoms with motor worsening.

Ravan A, Ahmad FM, Chabria S, Gadhari M, Sankhla CS.

Neurol India · 2015-03-01

DOI: 10.4103/0028-3886.156276PMID: 25947979

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.

1.057 makale bulundu

Loss of phosphodiesterase 10A expression is associated with progression and severity in Parkinson's disease.

Impact of Depression on Progression of Impairment and Disability in Early Parkinson's Disease.

The Natural Progression of Parkinson's Disease in a Small Cohort with 15 Drug-naïve Patients.

Vascular risk factors aggravate the progression of Parkinson's disease: a five-year follow-up study in Chinese patients.

Syntax, action verbs, action semantics, and object semantics in Parkinson's disease: Dissociability, progression, and executive influences.

Abnormal Olfaction in Parkinson's Disease Is Related to Faster Disease Progression.

Novel recruitment strategy to enrich for LRRK2 mutation carriers.

Clinically meaningful parameters of progression and long-term outcome of Parkinson disease: An international consensus statement.

Features of alpha-synuclein that could explain the progression and irreversibility of Parkinson's disease.

Transcranial magnetic stimulation follow-up study in early Parkinson's disease: A decline in compensation with disease progression?

Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease.

Non-motor symptoms in an Indian cohort of Parkinson's disease patients and correlation of progression of non-motor symptoms with motor worsening.

Filtreler